https://www.selleckchem.com/products/fgf401.html
BACKGROUND Depressive symptoms are common in individuals suffering from severe somatic conditions. There is a lack of interventions and evidence-based interventions aiming to reduce depressive symptoms in patients with severe somatic conditions. The aim of the NEVERMIND project is to address these issues and provide evidence by testing the NEVERMIND system, designed to reduce and prevent depressive symptoms in comparison to treatment as usual. METHODS The NEVERMIND study is a parallel-groups, pragmatic randomised controlled trial to asse
Like
Comment
Share
